| 34.792 -0.976 (-2.73%) | 05-15 15:26 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 41.2 |
1-year : | 42.85 |
| Resists | First : | 35.27 |
Second : | 36.68 |
| Pivot price | 35.11  |
|||
| Supports | First : | 32.99 |
Second : | 27.44 |
| MAs | MA(5) : | 35.67 |
MA(20) : | 35.04 |
| MA(100) : | 32.89 |
MA(250) : | 28.63 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 55.1 |
D(3) : | 67.5 |
| RSI | RSI(14): 50.5 |
|||
| 52-week | High : | 37 | Low : | 21.56 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBRN ] has closed above bottom band by 39.8%. Bollinger Bands are 18.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.86 - 35.11 | 35.11 - 35.29 |
| Low: | 34.16 - 34.5 | 34.5 - 34.76 |
| Close: | 34.35 - 34.8 | 34.8 - 35.15 |
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Fri, 08 May 2026
(IBRN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Mon, 27 Apr 2026
(IBRN) Risk Channels and Responsive Allocation - Stock Traders Daily
Thu, 18 Jul 2024
Where to Invest in Health Trends - Bloomberg.com
Wed, 31 Jan 2024
Neuralink Stock Price, Symbol: How to Invest in Neuralink IPO? - CoinCodex
Fri, 22 Dec 2023
Three Investing Themes For 2024, From AI To Globalization - Finimize
Wed, 22 Mar 2023
Healthcare Stocks List: Top Healthcare Companies & ETFs - Bullish Bears
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|